BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10711600)

  • 1. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts.
    Yoshida R; Oku T; Takikawa O; Einaga-Naito K; Yoneda Y; Hirota R; Kubota T
    Microbiol Immunol; 2000; 44(1):57-67. PubMed ID: 10711600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
    Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
    Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of H-2d-specific cytotoxic macrophage with unique morphology into rejection site of allografted meth A (H-2d) tumor cells in C57BL/6 (H-2b) mice.
    Nomi H; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    Microbiol Immunol; 2007; 51(3):297-306. PubMed ID: 17380049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells.
    Yoneda Y; Tashiro-Yamaji J; Kubota T; Yoshida R
    Microbiol Immunol; 2008 Jul; 52(7):349-56. PubMed ID: 18667033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells.
    Yamamoto N; Einaga-Naito K; Kuriyama M; Kawada Y; Yoshida R
    Transplantation; 1998 Mar; 65(6):818-25. PubMed ID: 9539094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel receptor on allograft (H-2d)-induced macrophage (H-2b) toward an allogeneic major histocompatibility complex class I molecule, H-2Dd, in mice.
    Tashiro-Yamaji J; Einaga-Naito K; Kubota T; Yoshida R
    Microbiol Immunol; 2006; 50(2):105-16. PubMed ID: 16490928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice.
    Nomi H; Tashiro-Yamaji J; Yamamoto Y; Miura-Takeda S; Miyoshi-Higashino M; Takahashi T; Azuma H; Ueda H; Katsuoka Y; Kubota T; Yoshida R
    J Immunol; 2007 Aug; 179(4):2180-6. PubMed ID: 17675477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure to reject an allografted tumor after elimination of macrophages in mice.
    Ushio Y; Yamamoto N; Sanchez-Bueno A; Yoshida R
    Microbiol Immunol; 1996; 40(7):489-98. PubMed ID: 8865154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage MHC and T-cell receptors essential for rejection of allografted skin and lymphoma.
    Tashiro-Yamaji J; Maeda S; Ikawa M; Okabe M; Kubota T; Yoshida R
    Transplantation; 2013 Aug; 96(3):251-7. PubMed ID: 23836286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage.
    Ushio-Umeda Y; Yoshida R
    Microbiol Immunol; 1997; 41(12):981-90. PubMed ID: 9492184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.
    Yoshimura R; Chargui J; Aitouche A; Veyron P; Touraine JL
    Transplantation; 2000 Apr; 69(7):1452-7. PubMed ID: 10798770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cardiac allografts with established leukocyte infiltration by modulation of alpha4 (CD49d) and leukocyte function-associated antigen-1 (CD11a/CD18) integrin function.
    Chan BM; Zheng H; Wang H; Uniyal S; Garcia B; Wang J; Zhong R
    Transplantation; 1998 Aug; 66(3):277-83. PubMed ID: 9721793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte integrin Mac-1 promotes acute cardiac allograft rejection.
    Shimizu K; Libby P; Shubiki R; Sakuma M; Wang Y; Asano K; Mitchell RN; Simon DI
    Circulation; 2008 Apr; 117(15):1997-2008. PubMed ID: 18378617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.
    Mayumi H; Good RA
    J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site.
    Yoneda Y; Yoshida R
    J Immunol; 1998 Jun; 160(12):6012-7. PubMed ID: 9637516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.